5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine

Inflammatory Bowel Diseases
Scott HandeSonia Friedman

Abstract

Small uncontrolled trials have suggested that 5-aminosalicylate (5-ASA) medications increase 6-thioguanine nucleotide (6-TGn) levels in adults with Crohn's disease (CD) on azathioprine (AZA) or 6-mercaptopurine (6-MP), presumably through the inhibition of thiopurine methyltransferase (TPMT). We tested the theory that coadministration of 5-ASA agents with AZA/6-MP results in higher 6-TGn levels in a large cohort of children and adults with CD or ulcerative colitis (UC). A retrospective cohort study identified all children and adults treated for IBD with AZA/6-MP at 2 tertiary medical centers. Patients were included if their TPMT genotype was known and 6-TGn and 6-methymercaptopurine (6-MMP) levels had been obtained after 3 months of clinical remission at a stable dose of AZA/6-MP. 6-TGn and 6-MMP levels were compared between patients taking and those not taking 5-ASA medications through the use of linear regression models to identify and adjust for potentially confounding variables. Of the 126 patients included, 88 were taking 5-ASA medications. Patients on 5-ASA agents had higher mean 6-TGn levels after adjustment for confounding variables (Delta6-TGn, 47.6 +/- 21.8 pmol/8 x 10 red blood cells; P = 0.03). CD and TPMT heterozygo...Continue Reading

References

Jan 1, 1992·European Journal of Clinical Pharmacology·L Lennard
Jul 4, 1992·BMJ : British Medical Journal·A B HawthorneJ E Lennard-Jones
Oct 1, 1983·British Journal of Clinical Pharmacology·L LennardJ L Maddocks
Jul 15, 1995·Annals of Internal Medicine·D C PearsonL R Sutherland
Sep 1, 1993·The American Journal of Medicine·G RivierG R Hughes
Nov 14, 1997·Clinical Pharmacology and Therapeutics·L D LewisD W Nierenberg
Oct 21, 1998·Therapeutic Drug Monitoring·M A Huestis, E J Cone
May 20, 1999·Annual Review of Pharmacology and Toxicology·R M WeinshilboumC L Szumlanski
Mar 11, 2000·The Journal of Laboratory and Clinical Medicine·G DecauxJ P Desager
Nov 6, 2001·The American Journal of Gastroenterology·S V KaneS B Hanauer
Feb 22, 2002·Alimentary Pharmacology & Therapeutics·O DewitY Horsmans
Jun 6, 2002·Alimentary Pharmacology & Therapeutics·N Vakil
Sep 9, 2004·Alimentary Pharmacology & Therapeutics·S B Hanauer

❮ Previous
Next ❯

Citations

Nov 16, 2006·Current Gastroenterology Reports·Geoffrey C NguyenThemistocles Dassopoulos
May 1, 2010·Therapeutic Advances in Chronic Disease·Fernando Bermejo, Javier P Gisbert
Nov 26, 2009·Patient Preference and Adherence·Daniel B Zandman, Mark A Peppercorn
Mar 27, 2009·World Journal of Gastroenterology : WJG·Giovanni-C ActisFloriano Rosina
Nov 8, 2011·Digestive Diseases and Sciences·Jae Jun ParkWon Ho Kim
Mar 7, 2012·Expert Review of Clinical Pharmacology·Maggie Ham, Alan C Moss
Apr 2, 2014·Expert Review of Gastroenterology & Hepatology·Lauren BeswickMiles P Sparrow
Oct 13, 2007·Expert Opinion on Pharmacotherapy·A R Bremner, R M Beattie
Aug 10, 2015·Clinical Pharmacokinetics·Mehmet CoskunOle Haagen Nielsen
Feb 29, 2008·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·L Y KwanK A Papadakis
Apr 28, 2009·Alimentary Pharmacology & Therapeutics·J P GisbertF Gomollón
Nov 29, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Nanne K H de BoerChris J J Mulder
Jun 19, 2008·Alimentary Pharmacology & Therapeutics·A AnsariJ Duley
Mar 7, 2014·British Journal of Clinical Pharmacology·Anastasia KonidariWael El-Matary
Aug 22, 2013·British Journal of Clinical Pharmacology·Lynne Lennard
Jan 11, 2014·Alimentary Pharmacology & Therapeutics·J P Gisbert, M Chaparro
Dec 4, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Simone SaibeniUNKNOWN Italian Group for Inflammatory Bowel Disease
Dec 19, 2014·Pharmacogenomics·Konstantinos H Katsanos, Konstantinos A Papadakis
Sep 4, 2007·The American Journal of Gastroenterology·Nanne K H de BoerAdriaan A van Bodegraven
Jun 12, 2014·Journal of Pediatric Gastroenterology and Nutrition·U KopylovE G Seidman
Jul 8, 2017·Pharmacogenomics·Sara RufiniPaola Borgiani
Oct 10, 2013·Inflammatory Bowel Diseases·Neal S LeLeikoBarbara Bancroft
Oct 16, 2010·Inflammatory Bowel Diseases·Jean-Baptiste ChevauxMiles P Sparrow
Jun 1, 2018·Journal of Pediatric Gastroenterology and Nutrition·Dan TurnerRichard K Russell
Jan 5, 2013·Journal of Pediatric Gastroenterology and Nutrition·Keith BenkovUNKNOWN NASPGHAN Committee on Inflammatory Bowel Disease
Aug 22, 2014·Journal of Pediatric Gastroenterology and Nutrition·Hanh D VoSteven M Schwarz
Jul 15, 2015·World Journal of Gastroenterology : WJG·Gordon W MoranRemo Panaccione
Sep 10, 2019·Expert Opinion on Biological Therapy·Catherine Le BerreLaurent Peyrin-Biroulet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.